Malaria in Venezuela: changes in the complexity of infection reflects the increment in transmission intensity.
Drug resistance genes
Multiplicity of infection
Pfdhfr
Pfdhps
Pfk13 gene
Plasmodium falciparum
Plasmodium vivax
Transmission intensity
Venezuela
microsatellites
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
07 May 2020
07 May 2020
Historique:
received:
02
03
2020
accepted:
26
04
2020
entrez:
9
5
2020
pubmed:
10
5
2020
medline:
15
12
2020
Statut:
epublish
Résumé
Malaria incidence has reached staggering numbers in Venezuela. Commonly, Bolívar State accounted for approximately 70% of the country cases every year. Most cases cluster in the Sifontes municipality, a region characterized by an extractive economy, including gold mining. An increase in migration to Sifontes, driven by gold mining, fueled a malaria spillover to the rest of the country and the region. Here samples collected in 2018 were compared with a previous study of 2003/2004 to describe changes in the parasites population structures and the frequency of point mutations linked to anti-malarial drugs. A total of 88 Plasmodium falciparum and 94 Plasmodium vivax isolates were collected in 2018 and compared with samples from 2003/2004 (106 P. falciparum and 104 P. vivax). For P. falciparum, mutations linked to drug resistance (Pfdhfr, Pfdhps, and Pfcrt) and the Pfk13 gene associated with artemisinin delayed parasite clearance, were analysed. To estimate the multiplicity of infection (MOI), and perform P. falciparum and P. vivax population genetic analyses, the parasites were genotyped by using eight standardized microsatellite loci. The P. falciparum parasites are still harbouring drug-resistant mutations in Pfdhfr, Pfdhps, and Pfcrt. However, there was a decrease in the frequency of highly resistant Pfdhps alleles. Mutations associated with artemisinin delayed parasite clearance in the Pfk13 gene were not found. Consistent with the increase in transmission, polyclonal infections raised from 1.9% in 2003/2004 to 39% in 2018 in P. falciparum and from 16.3 to 68% in P. vivax. There is also a decrease in linkage disequilibrium. Bayesian clustering yields two populations linked to the time of sampling, showing that the parasite populations temporarily changed. However, the samples from 2003/2004 and 2018 have several alleles per locus in common without sharing multi-locus genotypes. The frequency of mutations linked with drug resistance in P. falciparum shows only changes in Pfdhps. Observations presented here are consistent with an increase in transmission from the previously circulating parasites. Following populations longitudinally, using molecular surveillance, provides valuable information in cases such as Venezuela with a fluid malaria situation that is affecting the regional goals toward elimination.
Sections du résumé
BACKGROUND
BACKGROUND
Malaria incidence has reached staggering numbers in Venezuela. Commonly, Bolívar State accounted for approximately 70% of the country cases every year. Most cases cluster in the Sifontes municipality, a region characterized by an extractive economy, including gold mining. An increase in migration to Sifontes, driven by gold mining, fueled a malaria spillover to the rest of the country and the region. Here samples collected in 2018 were compared with a previous study of 2003/2004 to describe changes in the parasites population structures and the frequency of point mutations linked to anti-malarial drugs.
METHODS
METHODS
A total of 88 Plasmodium falciparum and 94 Plasmodium vivax isolates were collected in 2018 and compared with samples from 2003/2004 (106 P. falciparum and 104 P. vivax). For P. falciparum, mutations linked to drug resistance (Pfdhfr, Pfdhps, and Pfcrt) and the Pfk13 gene associated with artemisinin delayed parasite clearance, were analysed. To estimate the multiplicity of infection (MOI), and perform P. falciparum and P. vivax population genetic analyses, the parasites were genotyped by using eight standardized microsatellite loci.
RESULTS
RESULTS
The P. falciparum parasites are still harbouring drug-resistant mutations in Pfdhfr, Pfdhps, and Pfcrt. However, there was a decrease in the frequency of highly resistant Pfdhps alleles. Mutations associated with artemisinin delayed parasite clearance in the Pfk13 gene were not found. Consistent with the increase in transmission, polyclonal infections raised from 1.9% in 2003/2004 to 39% in 2018 in P. falciparum and from 16.3 to 68% in P. vivax. There is also a decrease in linkage disequilibrium. Bayesian clustering yields two populations linked to the time of sampling, showing that the parasite populations temporarily changed. However, the samples from 2003/2004 and 2018 have several alleles per locus in common without sharing multi-locus genotypes.
CONCLUSIONS
CONCLUSIONS
The frequency of mutations linked with drug resistance in P. falciparum shows only changes in Pfdhps. Observations presented here are consistent with an increase in transmission from the previously circulating parasites. Following populations longitudinally, using molecular surveillance, provides valuable information in cases such as Venezuela with a fluid malaria situation that is affecting the regional goals toward elimination.
Identifiants
pubmed: 32380999
doi: 10.1186/s12936-020-03247-z
pii: 10.1186/s12936-020-03247-z
pmc: PMC7206825
doi:
Substances chimiques
Antimalarials
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
176Subventions
Organisme : National Institute of Allergy and Infectious Diseases
ID : 2U19 AI089681
Organisme : German Academic Exchange
ID : Project-ID 57417782
Organisme : NIAID NIH HHS
ID : U19 AI089681
Pays : United States
Organisme : Deutsche Forschungsgemeinschaft
ID : Project-ID 656983
Organisme : SMWK-SAB
ID : Project-ID 100257255
Références
Gene. 2008 Feb 29;410(1):105-12
pubmed: 18226474
Proc Natl Acad Sci U S A. 1973 Dec;70(12):3321-3
pubmed: 4519626
Malar J. 2019 May 7;18(1):163
pubmed: 31064369
Antimicrob Agents Chemother. 2009 May;53(5):2042-51
pubmed: 19258269
PLoS Negl Trop Dis. 2019 Mar 28;13(3):e0007310
pubmed: 30921317
PLoS Negl Trop Dis. 2016 Jan 11;10(1):e0004355
pubmed: 26751811
Malar J. 2015 Sep 22;14:363
pubmed: 26395166
Antimicrob Agents Chemother. 2007 Jun;51(6):2085-91
pubmed: 17283199
Acta Trop. 2012 Mar;121(3):303-14
pubmed: 21741349
Mem Inst Oswaldo Cruz. 2014 Aug;109(5):525-33
pubmed: 25184998
PLoS One. 2018 Apr 9;13(4):e0194148
pubmed: 29630605
Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):79-86
pubmed: 26259945
J Infect Dis. 2002 Oct 1;186(7):999-1006
pubmed: 12232841
Bioinformatics. 2007 Jul 15;23(14):1801-6
pubmed: 17485429
Microbiol Spectr. 2019 Jul;7(4):
pubmed: 31400095
Malar J. 2019 Dec 3;18(1):391
pubmed: 31796087
J Infect Dis. 2018 Jan 30;217(4):622-627
pubmed: 29325146
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11672-7
pubmed: 26261345
Emerg Infect Dis. 2019 Apr;25(4):834-836
pubmed: 30698522
Lancet Infect Dis. 2019 May;19(5):e149-e161
pubmed: 30799251
Bioinformatics. 2009 Jun 1;25(11):1451-2
pubmed: 19346325
Genetics. 2014 Sep;198(1):321-31
pubmed: 25023400
Antimicrob Agents Chemother. 2008 Feb;52(2):739-41
pubmed: 18025120
Am J Trop Med Hyg. 2020 Feb;102(2):310-312
pubmed: 31833470
Emerg Infect Dis. 2019 Feb;25(2):355-357
pubmed: 30666942
BMC Bioinformatics. 2009 May 18;10:152
pubmed: 19450271
Parasitol Res. 2019 Oct;118(10):3085-3089
pubmed: 31396714
Malar J. 2009 Jun 27;8:142
pubmed: 19558695
Mol Biol Evol. 2006 May;23(5):1016-8
pubmed: 16507919
PLoS Negl Trop Dis. 2015 Dec 28;9(12):e0004252
pubmed: 26709695
J Infect Dis. 2016 May 1;213(9):1472-5
pubmed: 26690347
PLoS One. 2014 Jul 02;9(7):e97899
pubmed: 24988302
Parasitology. 1999 Aug;119 ( Pt 2):113-25
pubmed: 10466118
Genetics. 2000 Jun;155(2):945-59
pubmed: 10835412
Antimicrob Agents Chemother. 2019 Jul 25;63(8):
pubmed: 31085516
Malar J. 2017 Jul 4;16(1):273
pubmed: 28676055
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Am J Trop Med Hyg. 2017 Mar;96(3):630-641
pubmed: 28070005
Malar J. 2014 Jun 25;13:244
pubmed: 24964730
Open Forum Infect Dis. 2018 Sep 21;5(11):ofy240
pubmed: 30397622
Antimicrob Agents Chemother. 2010 Apr;54(4):1572-9
pubmed: 20145087
Malar J. 2012 Dec 11;11:412
pubmed: 23232077